Reimbursement authority NICE has said that Incyte's JAK inhibitor cream Opzelura (ruxolitinib) can be used to treat people ...

Childhood Cancer Survivor Study Participants' Perceptions and Understanding of the Affordable Care Act One hundred thirty-seven studies were identified comprising 139 treatment arms (11 general immune ...

Please provide your email address to receive an email when new articles are posted on . Confetti-like depigmentation could be a marker of rapidly progressing vitiligo, according to study results.

If you’re living with vitiligo, an autoimmune condition that causes skin to lose its pigment, you might have complex feelings about how it can affect your appearance. You’re not alone in that: ...

A condition that causes the skin to lose pigmentation, vitiligo affects around one per cent of the UK population. The long-term disorder, in which white patches of skin appear on different parts of ...

This article is sponsored by Incyte. Vitiligo is a chronic autoimmune condition that manifests as white patches of depigmented skin, or a complete loss of color, on affected areas of the body. The ...

Patients with vitiligo will now have access to the first ever at-home therapy for skin repigmentation approved by the Food and Drug Administration. Jim Lee, vice president for Incyte’s head ...

(HealthDay News) — Confetti-like depigmentation may be a marker of rapidly progressing vitiligo, according to a review published in the August issue of the Journal of the American Academy of ...

Vitiligo is an autoimmune condition that causes areas of skin to lose color or pigment. It isn’t just visible to others. You can see it on yourself. And I talk with people all the time about how this ...